Загрузка...
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
BACKGROUND: Continuous erythropoiesis receptor activator (CERA) is a newer, longer acting ESA which might be preferred to other ESAs (epoetin or darbepoetin) based on its lower frequency of administration. Different dosing requirements and molecular characteristics of CERA compared with other ESAs m...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2017
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483666/ https://ncbi.nlm.nih.gov/pubmed/28782299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009904.pub2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|